ArticleBrazilian dental journal2025
SHED-Secretome Gel Promotes Early Alveolar Bone Healing via Osteoblast-Osteoclast Modulation.
Article in Brazilian dental journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-extraction alveolar bone healing is crucial for dental rehabilitation, depending on the balance between osteoblast and osteoclast activity. This study evaluated the potential of SHED (stem cells from human exfoliated deciduous teeth)-derived secretome gel in promoting bone regeneration. Eighteen male Rattus norvegicus were divided into three groups: negative control (placebo gel), positive control (absorbable gelatin sponge), and treatment (SHED-secretome gel). Maxillary first molars were extracted, and the respective materials were applied to the sockets. On day 7, histological samples were analyzed. Results showed that the SHED-secretome group exhibited significantly higher osteoblast and osteoclast numbers compared to controls, indicating active and balanced bone remodeling. The bone matrix appeared more organized, suggesting accelerated early healing. Statistical analysis (Kruskal-Wallis and Mann-Whitney U with Bonferroni correction) confirmed significant differences (p < 0.01) in osteoblast and osteoclast counts across groups. In conclusion, SHED-secretome gel enhances early alveolar bone healing by promoting coordinated osteoblast-osteoclast activity essential for physiological bone remodeling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.